<code id='BBA85EA77A'></code><style id='BBA85EA77A'></style>
    • <acronym id='BBA85EA77A'></acronym>
      <center id='BBA85EA77A'><center id='BBA85EA77A'><tfoot id='BBA85EA77A'></tfoot></center><abbr id='BBA85EA77A'><dir id='BBA85EA77A'><tfoot id='BBA85EA77A'></tfoot><noframes id='BBA85EA77A'>

    • <optgroup id='BBA85EA77A'><strike id='BBA85EA77A'><sup id='BBA85EA77A'></sup></strike><code id='BBA85EA77A'></code></optgroup>
        1. <b id='BBA85EA77A'><label id='BBA85EA77A'><select id='BBA85EA77A'><dt id='BBA85EA77A'><span id='BBA85EA77A'></span></dt></select></label></b><u id='BBA85EA77A'></u>
          <i id='BBA85EA77A'><strike id='BBA85EA77A'><tt id='BBA85EA77A'><pre id='BBA85EA77A'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:9442
          Silhouette of a medical staff, followed by another, running pushing a nursing bed. Two people talk next to the hurrying staff in the corridor — coverage from STAT
          Adobe

          There’s ample evidence that private equity buyouts in health care drive up costs. A new study shows quality declines, too.

          Hospitals acquired by private equity saw a 25% uptick in adverse events compared with controls, according to a new study released today in the Journal of the American Medical Association. The findings add to an accumulating body of literature underscoring the harm that occurs when financial investors take over health care providers — not only hospitals, but nursing homes, hospice care, and physician practices.

          advertisement

          Even after adjusting their findings to be more conservative, the researchers on the JAMA study found that all of the hospital-acquired conditions they studied increased three years after a private equity acquisition compared to control hospitals. Not all of the increases were statistically significant.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          The biotech scorecard for the 2nd quarter: 12 industry events to watch
          The biotech scorecard for the 2nd quarter: 12 industry events to watch

          APStockIntroducingSTAT’sBiotechQ2Scorecard,ouremoji-enabledmeansoftracking12make-or-breakeventsexpec

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Patient advocates sound warning on FDA proposal on salt intake

          Potassiumchloride:Forpeoplewithkidneydisease,especiallyBlackAmericans,itmaybeadeadlysubstituteforsal